NCT00493662View on ClinicalTrials.gov

Cross-Over Evaluation of Two Lubricating Eye Drops

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Dry Eye

Interventions

DRUG

Polyethylene Glycol 400 0.4%

DRUG

Propylene Glycol 0.3%

DRUG

0.15% sodium Hyaluronate

DRUG

sodium chloride

DRUG

sodium phosphate monobasic

Trial Locations (1)

18202

Hazleton Eye Specialists, Hazleton

Sponsors

Lead Sponsor

Innovative Medical

All Listed Sponsors

lead

Innovative Medical

INDUSTRY

NCT00493662 - Cross-Over Evaluation of Two Lubricating Eye Drops | Biotech Hunter | Biotech Hunter